Pfizer (PFE) stock gains as lung cancer therapy, Lorbrena, shows promising results in reducing disease progression or death ...

The European Medicines Agency has recommended the use of Pfizer's gene therapy for a rare bleeding disorder called hemophilia ...

Researchers are engineering ways to alter genes or swap flawed ones with healthy replacements, hoping to cure diseases or enable the body to better combat them.

But the head of the FDA’s CBER office didn’t tip where the agency stands on potentially broadening use of Sarepta’s Duchenne gene therapy Elevidys.

The only approved therapy is cornstarch, which due to its slow digestion in the body results in a slow, steady release of ...

This health news summary spotlights major developments in cancer treatments, regulatory actions on biotechnology, and the ...

Kendric Cromer is the first commercial patient to ... percent of them are African American. The FDA approved Bluebird Bio’s Lovo-Cel Gene Therapy last year. Before the gene therapy, Kendric ...

The global cell and gene therapy market is experiencing significant growth, driven by technological advancements, increasing ...

Recently, the FDA approved Adstiladrin, the first gene therapy for bladder cancer. It's for patients whose cancer returns after the standard treatment BCG, Bacillus Calmette-Guerin. A modified ...

Providing a new alternative is Tris Pharma, which has won FDA approval for Onyda XR (clonidine hydrochloride). The extended-release oral suspension becomes the first liquid non-stimulant ...

Agios Pharmaceuticals announced a $905 million purchase with Royalty Pharma —Pheon Therapeutics raised a $120 million Series ...

The European Medicines Agency has recommended the use of Pfizer's gene therapy for a rare bleeding disorder called hemophilia B, which typically requires regular infusions of a blood-clotting protein, ...